Spectrin αII inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of spectrin αII, a crucial component of the spectrin cytoskeleton, which plays a vital role in maintaining cellular structure, stability, and mechanical resilience. Spectrin αII, along with its partner subunit spectrin β, forms a flexible, lattice-like network just beneath the plasma membrane, linking the cytoskeleton to the membrane and various membrane-associated proteins. This structure is essential for preserving cell shape, enabling cells to endure mechanical stress, and organizing intracellular compartments. Spectrin αII is particularly important in tissues where mechanical stability and cellular integrity are critical, such as in red blood cells, neurons, and muscle cells. By inhibiting spectrin αII, researchers can disrupt these essential structural and organizational roles, providing a powerful tool to study the specific contributions of spectrin αII to cellular architecture and function.
In research, spectrin αII inhibitors are valuable for exploring the molecular mechanisms by which spectrin αII supports cytoskeletal organization and the broader impact of its inhibition on cellular physiology. By blocking the activity of spectrin αII, scientists can investigate how the loss of this protein affects cellular shape, elasticity, and the ability to withstand mechanical forces. This inhibition also allows researchers to study the downstream effects on processes dependent on the spectrin cytoskeleton, such as vesicle trafficking, signal transduction, and membrane protein organization. Additionally, spectrin αII inhibitors provide insights into the interactions between spectrin αII and other cytoskeletal elements, such as actin, as well as its role in maintaining the integrity of specialized cellular structures, like axons in neurons or the cortical cytoskeleton in epithelial cells. Through these studies, the use of spectrin αII inhibitors enhances our understanding of the fundamental role of the cytoskeleton in maintaining cellular architecture, the regulation of cellular dynamics, and the broader implications of spectrin function in health and disease.
SEE ALSO...
Items 1 to 10 of 16 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Furosemide | 54-31-9 | sc-203961 | 50 mg | $41.00 | ||
Furosemide is a diuretic agent in research that can indirectly inhibit spectrin alpha II by affecting electrolyte balance, particularly by decreasing intracellular potassium levels. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid may downregulate spectrin αII expression by activating retinoic acid receptors that can suppress transcription of specific cytoskeletal genes. | ||||||
Amiloride • HCl | 2016-88-8 | sc-3578 sc-3578A | 25 mg 100 mg | $22.00 $57.00 | 6 | |
Amiloride is another diuretic that can indirectly influence spectrin alpha II function by interfering with sodium transport, which can affect erythrocyte shape and stability. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A may lead to the upregulation of genes that produce repressors of spectrin αII transcription through inhibition of histone deacetylases. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferases, 5-Azacytidine could decrease methylation levels, potentially leading to a reduction in spectrin αII gene promoter activity. | ||||||
Phalloidin | 17466-45-4 | sc-202763 | 1 mg | $234.00 | 33 | |
Phalloidin is a toxin produced by certain mushrooms that can bind to and stabilize F-actin filaments, indirectly affecting spectrin alpha II′s role in cytoskeletal stability. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A might bind to GC-rich sequences in the promoter region of the spectrin αII gene, leading to a decrease in its transcriptional initiation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride may disrupt Wnt/β-catenin signaling, leading to transcriptional repression of downstream target genes, which could include spectrin αII. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 could potentially inhibit MEK activity, which in turn may lead to decreased ERK phosphorylation and subsequent downregulation of spectrin αII transcription. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
By inhibiting PI3K, LY 294002 may reduce AKT activity and downregulate nuclear transcription factors, culminating in decreased spectrin αII mRNA synthesis. | ||||||